Status:
COMPLETED
Levosimendan in High Risk Patients Undergoing Cardiac Surgery
Lead Sponsor:
Università Vita-Salute San Raffaele
Conditions:
Low Cardiac Output Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Low cardiac output syndrome (LCOs) is a serious complication in critically ill patients or those undergoing major surgery, resulting in multiple organ damage with significant in-hospital and long-term...
Detailed Description
Low cardiac output syndrome (LCOs) is a serious complication in critically ill patients or those undergoing major surgery, resulting in multiple organ damage with significant in-hospital and long-term...
Eligibility Criteria
Inclusion
- Written informed consent
- Age \> 18 years
- Perioperative myocardial dysfunction
Exclusion
- Previous unusual response to levosimendan or soluvit or any of their components
- Inclusion in other randomised controlled studies in the previous 30 days
- Levosimendan administration in the previous 30 days
- Parkinson's disease
- Emergency operation
- Kidney or liver transplant
- Liver cirrhosis (Child B or C)
- Decision to use ECMO (ECMO already started or planned)
- Do not resuscitate patient
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00994825
Start Date
November 1 2009
End Date
May 1 2016
Last Update
July 22 2016
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Santa Casa de Misericórdia de Juiz de Fora
Juiz de Fora, Minas Gerais, Brazil, 36.021- 630
2
Policlinico S.Orsola-Malpighi
Bologna, Italy, Italy, 40138
3
Azienda Ospedaliera Universitaria San Martino
Genova, Italy, Italy, 16132
4
Azienda Ospedaliera Ospedali Riuniti Papardo - Piemonte
Messina, ME, Italy, 98158